Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer
Forum INTUITIVE SURGIC
392.6200 (c) USD
-0.92% 
Ouverture théorique 388.2700
valeur indicative 362.0545 EUR

US46120E6023 ISRG

NASDAQ données temps différé
Chargement...
  • ouverture

    399.6000

  • clôture veille

    396.2800

  • + haut

    401.2700

  • + bas

    390.7900

  • volume

    0

  • capital échangé

    0.00%

  • valorisation

    138 330 MUSD

  • capi. boursière

    Capitalisation Boursière

    Fermer

    139 459 MUSD

  • dernier échange

    18.03.24 / 21:00:03

  • limite à la baisse

    Qu'est-ce qu'une limite à la hausse/baisse ?

    Fermer

    447.8400

  • limite à la hausse

    Qu'est-ce qu'une limite à la hausse/baisse ?

    Fermer

    0.0000

  • rendement estimé 2024

    -

  • PER estimé 2024

    Qu'est-ce que le PER ?

    Fermer

    61.57

  • dernier dividende

    A quoi correspond le montant du dernier dividende versé ?

    Fermer

    -

  • date dernier dividende

    -

  • Éligibilité

    -

  • Risque ESG

    Qu'est-ce que le risque ESG ?

    Fermer

    21.1/100 (moyen)

  • + Portefeuille

  • + Liste

Retour au sujet INTUITIVE SURGICAL

INTUITIVE SURGIC : Intuitive Surgical Shares Rise

19 oct. 200719:00

Intuitive Surgical Shares Rise As 3Q Profit Doubles, Analysts Lift Price Target to $325


NEW YORK (AP) -- Shares of robotic surgical tool maker Intuitive Surgical Inc. hit an all-time high Friday after the company said third-quarter profit doubled on sales of its da Vinci surgical system, prompting some analysts to lift their price targets all the way to $325.
ADVERTISEMENT


The stock rose $17.06, or 6.7 percent, to $273.50 in afternoon trading, having earlier hit an all-time high of $276.27 on heavy volume.

On Thursday, the company said sales of its da Vinci Surgical System rose 63 percent as more surgeons performed robotic procedures during the quarter.

Bear Stearns analyst Rick Wise increased his price target to $325 from $260 and reaffirmed a "Outperform" rating on the stock.

"Following another great quarter, we feel Intuitive shares could still drift higher, as we head into the company's typically seasonally strongest fourth quarter and procedure adoption continues at an accelerated pace," he wrote in a note to investors.

The company placed 63 new systems during the third quarter, 6 more than Wise expected, and that momentum is likely to be sustained, he said.

Jefferies & Co. analyst Mark Richter reaffirmed a "Hold" rating but increased his price target to $293 from $140. He said the results show a continuation of consecutive quarterly growth for revenue and earnings.

"While we remain long-term supporters of the company and its core technology, we would wait for a better entry point due to the recent appreciation in the stock price," he said, explaining the "Hold" rating.

Meanwhile, Cowen and Co. analyst Eli Kammerman reaffirmed an "Outperform" rating and said use of the da Vinci system is expected to grow during the fourth quarter. HSBC also reiterated an "Overweight" rating and lifted its target price to $325 from $198.



0 réponse

Signaler le message

Fermer

Qui a recommandé ce message ?

Fermer
Retour au sujet INTUITIVE SURGICAL

Mes listes

Cette liste ne contient aucune valeur.